This not-for-profit initiative aims to rehabilitate & reset you & your home
The healthy home, healthy mind initiative program is designed to educate & empower you to take back control of your mental health, your environment & your life.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBC
22 minutes ago
- CBC
Expert discusses potential impact of Trump's demand to slash drug prices in U.S.
U.S. President Donald Trump has issued a direct warning to top pharmaceutical companies, demanding they slash drug prices. Mina Tadrous, an associate professor at the University of Toronto's Leslie Dan Faculty of Pharmacy, discusses concerns and how this could impact drug prices in Canada.
Globe and Mail
2 hours ago
- Globe and Mail
AstraZeneca's AZD3427 Study: A Potential Game-Changer for Heart Failure and Pulmonary Hypertension
AstraZeneca ((AZN)), Parexel International ((PRXL)), AstraZeneca plc ((GB:AZN)), AstraZeneca ((DE:ZEGA)), AstraZeneca plc US ((AZNCF)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. AstraZeneca, in collaboration with Parexel International, is conducting a Phase IIb study titled A Phase IIb Randomised, Double-blind, Placebo-controlled, Multi-centre, Dose-ranging Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Due to Left Heart Disease (WHO Group 2). The study aims to assess the efficacy of AZD3427 in reducing pulmonary vascular resistance in patients with heart failure and pulmonary hypertension over 24 weeks, highlighting its potential significance in treating these conditions. The intervention being tested is AZD3427, administered as a subcutaneous injection. It is designed to target pulmonary hypertension by reducing vascular resistance, with the study evaluating three different dose levels of the drug. The study follows a randomized, parallel assignment model with triple masking, involving participants, care providers, and investigators. Its primary purpose is treatment-focused, aiming to determine the optimal dosing strategy for AZD3427. The study began on April 24, 2023, with an estimated completion date in July 2025. These timelines are crucial for tracking the progress and potential market introduction of AZD3427. The outcome of this study could significantly impact AstraZeneca's market position, potentially boosting its stock performance if results are positive. Investors will be keenly watching for updates, especially in the context of competitive treatments for heart failure and pulmonary hypertension. The study is ongoing, with further details available on the ClinicalTrials portal.
CTV News
3 hours ago
- CTV News
Therapy dog visits Timmins Police Service to spread some cheer
The St. John Ambulance Therapy Dog Program in Timmins is back in business doing what it does best, spreading cuddly love to anyone in need. Many believe a sweet, cuddly dog has the power to turn just about anyone's day around. Take ' Takoda' for example – he's one of the many canines participating in the St. John Ambulance Therapy Dog Program and he's on a special assignment at the Timmins Police Service, one of many community partners. 'Right now we visit every day of the week except Friday. We do all the nursing homes except Extendicare,' said Wendy Lemieux, coordinator the program for the Timmins area. Police officials said the timing of the visit is perfect as 'Police Week' is wrapping up. 'It does allow for this group to interact with the Timmins Police Service and it allows for our officers to take a brief respite out of their busy days to socialize with an animal,' said Marc Depatie, the police service's communications coordinator. 'There's no downside that we can see and it does go very well with our mental health initiatives and strategies.' Lemieux said the Therapy Dog Program is just getting back on its feet following the last few years of pandemic restrictions and handlers said they're looking forward to visiting more organizations. 'When you walk into a facility and you go by someone's room, they may not be able to speak to you, but when they see the dog, they just light up and motion c'mon in and we have a visit and we go to the next room,' said Shelley Deslauriers, one of the therapy dog handler. 'It's just a really good feeling seeing them happy and then they talk about it for hours.' Takoda made sure no one was left without a lick at the police station. 'It's nice to have something positive and I don't have a dog at home so it's nice to be able to share a little bit of cuddle time and a bit of dog time here,' said Constable Caroline Rouillard. Lemieux said to contact the St. John Ambulance office to reserve time with one of the therapy dogs; or if you think you've got a calm and caring canine that would make a good therapy dog. Officials with the organization want the public to keep in mind there is a waiting list. For more information on St. John Ambulance programs in the Timmins area, visit their Facebook page.
